Aspirin and sodium salicylate inhibit endothelin ETA receptors by an allosteric type of mechanism

Molecular Pharmacology

Volumn 57, Issue 4, 2000, Pages 797-804

  Talbodec, Anne ^a   Berkane, Nathalie ^a   Blandin, Virginie ^a   Breittmayer, Jean Philippe ^b   Ferrari, Emile ^c   Frelin, Christian ^a   Vigne, Paul ^a  

^a CNRS   (France)

^b CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^c PASTEUR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BOSENTAN; CALCIUM ION; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST; IODINE 125; NEUROMEDIN B; SALICYLATE SODIUM; URIDINE TRIPHOSPHATE;

ALLOSTERISM; ANIMAL TISSUE; ARTICLE; BRAIN CAPILLARY; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CONTROLLED STUDY; DISSOCIATION; DRUG MECHANISM; DRUG POTENTIATION; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; ISCHEMIC HEART DISEASE; MAMMARY ARTERY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; THORACIC AORTA;

EID: 0034034074     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.57.4.797     Document Type: Article

References (36)

1. Balasubramanian SV, Straubinger RM and Morris ME (1997) Salicylic acid induced changes in the physical properties of model and native kidney membranes. J Pharm Sci 86:199-204.
2. Bradford MM (1976) A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye coupling. Anal Biochem 72:248-254.
3. Bruns RF and Fergus JH (1990) Allosteric enhancement of adenosine A1 receptor binding and function by 2-amino-3-benzoylthiophenes. Mol Pharmacal 38:939-949.
4. Cheng XM, Nikam SS and Doherty AM (1994) Development of agents to modulate the effects of endothelin. Curr Med Chem 1:271-312.
5. Clozel M, Breu V, Burri K, Cassai JM, Fischli W, Gray GA, Hirth G, Löffler BM, Müller M. Neidhart W and Ramuz H (1993) Pathophysiological role of endothelin by the first orally active endothelin receptor antagonist. Nature (Lond) 365:759-761.
6. Desmarets J, Gresser O, Guédin D and Frelin C (1996) Interaction of endothelin-1 with cloned bovine ETA receptors: Biochemical parameters and functional consequences. Biochemistry 35:14868-14875.
7. 2+ mobilization in brain capillary endothelial cells. J Biol Chem 268:8787-8792.
8. Frelin C and Guédin D (1994) Why are circulating concentrations of endothelin-1 so low? Cardiovasc Res 28:1613-1622.
9. Gresser O, Chayard D, Herbert D, Cousin MA, Le Moullec JM, Bouattane F, Guedin D and Frelin C (1996) Et-1 and Et-3 actions mediated by cloned ETA endothelin receptors exhibit different sensitivities to BQ-123. Biochem Biophys Res Comm 224:169-171.
10. Hilal-Dandan R, Villegas S, Gonzalez A and Brunton LL (1997) The quasiirreversible nature of endothelin binding and G protein-linked signaling in cardiac myocytes. J Pharmacol Exp Ther 281:267-273.
11. Hoare SRJ and Strange PG (1998) Regulation of D2 dopamine receptors by amiloride and amiloride analogs Mol Pharmacol 50:1295-1308.
12. ISIS-2 (1988) Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: (Second International Study of Infarct Survival) Collaborative Group. Lancet 2:349-360.
13. Leite FA, Page E and Ambler SK (1994) Regulation of ANP secretion by endothelin-1 in cultured atrial myocytes: Desensitization and receptor subtype. Am J Physiol 267:H2193-H2203.
14. Leppik RA, Lazareno S, Mynett A and Birdsall NJ (1998) Characterization of the allosteric interaction between antagonists and amiloride analogues at the human alpha2A-adrenergic receptor. Mol Pharmacol 53:916-925.
15. Maguire JJ and Davenport AP (1995) ETA receptor-mediated constrictor responses to endothelin peptides in human blood vessels in vitro. Br J Pharmacol 115:191-197.
16. Marsault R, Feolde E and Frelin C (1993) Receptor externalization determines sustained contractile responses to endothelin-1 in the rat aorta. Am J Physiol 264:C687-C693.
17. Marsault R. Vigne P, Breittmayer JP and Frelin C (1991) Kinetics of the vasoconstrictor action of endothelins. Am J Physiol 261:C986-C993.
18. Mulder P, Richard V, Derumeaux G, Hogie M, Henry JP, Lallemend F. Compagnon P, Mace B, Comoy E, Letac B and Thuillez C (1997) Role of endogenous endothelin in chronic heart failure: Effect of long-term treatment with an endothelin antagonist on survival, hemodynamics, and cardiac remodelling. Circulation 96:1976-1982.
19. Nambi P, Pullen M and Aiyar N (1996) Correlation between guanine nucleotide effect and reversible binding property of endothelin analogs. Neuropeptides 30: 109-114.
20. + exchange. J Biol Chem 262:12387-12392.
21. Oberle S, Polte T, Abate A, Podhaisky HP and Schröder H (1998) Aspirin increases ferritin synthesis in endothelial cells. A novel antioxidant pathway. Circ Res 82:1016-1020.
22. Omland T, Lie RT, Aakvaag A, Aarsland T and Dickstein K (1994) Plasma endothelin determination as a prognostic indicator of 1-year mortality after acute myocardial infarction. Circulation 89:1573-1579.
23. Patrono C (1994) Aspirin as an antiplatelet drug. N Engl J Med 330:1287-1294.
24. Patrono C and Roth GJ (1996) Aspirin in ischemic cerebrovascular disease. How strong is the case for a different dosing regimen? Stroke 27:756-760.
25. Schwenger P, Alpert D, Skolnik EY and Vilcek J (1998) Activation of p38 mitogen activated protein kinase by sodium salicylate leads to inhibition of tumor necrosis factor induced IκBα phosphorylation and degradation. Mol Cell Biol 18:78-84.
26. Schwenger P, Bellosta P, Vietor I, Basilico C, Skolnik EY and Vilcek J (1997) Sodium salicylate induces apoptosis via p38 mitogen activated protein kinase but inhibits tumor necrosis factor induced c-jun N-terminal kinase/stress-activated protein kinase activation. Proc Natl Acad Sci USA 94:2869-2873.
27. Seo B, Oemar BS, Siebenmann R, von Segesser L and Luscher TF (1994) Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels. Circulation 89:1203-1208.
28. Toyo-oka T, Aizawa T and Suzuki N (1991) Increased plasma levels of endothelin-1 and coronary spasm induction in patients with vasospastic angina pectoralis. Circulation 83:476-483.
29. Tucek S and Proska J (1995) Allosteric modulation of muscarinic acetylcholine receptors. Trends Pharmacol Sci 16:205-212.
30. Vigne P, Feolde E, Breittmayer JP and Frelin C (1994) Characterization of the effects of 2-methylthio-ATP and 2-chloro-ATP on brain capillary endothelial cells. Similarities to ADP and differences from ATP. Br J Pharmacol 112:775-780.
31. Vigne P, Feolde E, Van Renterghem C, Breittmayer JP and Frelin C (1995) Properties and functions of a neuromedin B preferring bombesin receptor in brain microvascular endothelial cells. Eur J Biochem 233:414-418.
32. Vigne P, Marsault R, Breittmayer JP and Frelin C (1990) Endothelin stimulates phosphatidylinositol hydrolysis and DNA synthesis in brain capillary endothelial cells. Biochem J 286:415-420.
33. 125I]endothelin-1 binding data. Life Sci 51:1869-1876.
34. Watala C and Gwozdzinski K (1993) Effect of aspirin on conformation and dynamics of membrane proteins in platelets and erythrocytes. Biochem Pharmacol 45:1343-1349.
35. Weiczorek I, Haynes WG, Ludlam C, Fox K and Webb DJ (1994) Plasma endothelin predicts outcome in patients with unstable myocardial ischaemic episodes. Br Heart J 72:436-441.
36. Yanagisawa M, Kurihara H, Kimura S, Mitsui Y, Kobayashi M, Watanabe TX and Masaki T (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature (Lond) 332:411-415.